Hematology Diagnostics Market Trends, Share, Size, Revenue, Competition and Future Outlook
Hematology Diagnostics Market Growth, Size, Trends Analysis- By Product, By Test Type, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
| Published: Nov-2024 | Report ID: HLCA2489 | Pages: 1 - 245 | Formats*: |
| Category : Healthcare | |||
Global Hematology Diagnostics Market Introduction and Overview
According to SPER Market Research, the Global Hematology Diagnostics Market is estimated to reach USD 17.68 billion by 2033 with a CAGR of 4.64%.
The report includes an in-depth analysis of the Global Hematology Diagnostics Market, including market size and trends, product mix, applications, and supplier analysis. Hematological diagnostics is a branch of medical diagnostics that looks at and analyzes blood and its constituent parts to identify and monitor a number of blood conditions, such as immune system diseases, coagulation disorders, anemia, and leukemia. It involves a wide range of laboratory procedures and tests to assess the makeup and functionality of blood, including hemoglobin, platelets, white blood cells, red blood cells, and hemoglobin, among other parameters, in order to inform treatment choices, monitor the course of the disease, and guarantee the general health of the patient. Hematological diagnostics are essential for revealing vital information about a patient's hematopoietic condition and are used in both clinical and research settings.
- Nihon Kohden introduced the MEK-1305 Celltac α+, an automated hematology and ESR analyzer, to the international market in December 2020. The Meyk1305 is a cutting-edge hematological analyzer that can measure ESR and a complete blood count, which includes a three-part white blood cell differential.
- HORIBA announced in June 2024 the release of the Yumizen H550E, H500E CT, and H500E OT, new compact hematology analyzers with combined CBC/Diff and ESR (erythrocyte sedimentation rate) testing capabilities. The CoRA (Correlated Rouleaux Analysis) technology, which these analyzers employ, provides quick and thorough findings along with cancer and infectious disease screening capabilities.
Market Opportunities and Challenges
Opportunities- The market for hematology diagnostics is expected to develop as a result of rising awareness of health and screening initiatives, the prevalence of chronic illnesses, and the widespread use of point-of-care testing. In May 2023, the World Health Organization (WHO) reported that anemia affects 40% of all children aged 6 to 59 months, 37% of pregnant women, and 30% of women aged 15 to 49 worldwide. Furthermore, Demand has also grown dramatically as a result of technological developments in diagnostic tools and procedures. Hematology tests are becoming more accurate, efficient, and wide-ranging because to innovations like automated analyzers, flow cytometry, and molecular diagnostics.
The acceptance of these technologies is further fueled by the ease with which healthcare providers can now diagnose complex illnesses and customize therapies for each patient. Furthermore, regular health examinations and preventive healthcare are becoming more and more important. Hematology tests are being used more frequently to track overall health and identify possible problems early on as a result of this change in healthcare practices. Regular screenings are also encouraged by public health programs and awareness efforts, which adds to the overall rise in demand.
Challenges- However, the market expansion for hematological diagnostics may be significantly hampered by a shortage of qualified personnel. One of the biggest barriers to social advancement and economic success in developing nations is the lack of trained workers. Lack of access to excellent medical care can result in higher mortality rates, less effective treatment outcomes, and a deficit of critical health services in the health sector. This is caused by a paucity of competent physicians, lab technicians, and other healthcare workers.
Market Competitive Landscape
The Global Hematology Diagnostics Market is highly consolidated. Some of the market key players are Abbott Laboratories, Cardinal Health Inc., Danaher Corporation, EKF Diagnostics Holdings plc, Erba Mannheim, F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens AG, Sysmex Corporation.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2020-2033 |
| Base year considered | 2023 |
| Forecast period | 2024-2033 |
| Segments covered | By Product, By Test Type, By End User |
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe |
| Companies Covered | Abbott Laboratories, Cardinal Health Inc., Danaher Corporation, EKF Diagnostics Holdings plc, Erba Mannheim, F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens AG, Sysmex Corporation. |
COVID-19 Impact on Global Hematology Diagnostics Market
The COVID-19 pandemic had a major impact on the global market for hematological diagnostics in a number of ways. The need for thorough testing increased as hematological evaluations became crucial for tracking COVID-19 patients' health and assessing how well they were responding to treatment. But the crisis also disrupted the supply chain, resulting in shortages of equipment, testing kits, and essential reagents, which impacted market availability. Furthermore, regular diagnostic procedures were delayed or cut back as healthcare resources were directed toward addressing COVID-19 cases.
Key Target Audience:
- Healthcare Providers
- Clinical Laboratories
- Hospitals and Healthcare Institutions
- Diagnostic Device Manufacturers
- Pharmaceutical Companies
- Research and Academic Institutions
- Government Health Agencies
- Patients and Patient Advocacy Groups
Our in-depth analysis of the Global Hematology Diagnostics Market includes the following segments:
| By Product: | |
| By Test Type: | |
| By End User: |
Key Topics Covered in the Report:
- Global Hematology Diagnostics Market Size (FY’2024-FY’2033)
- Overview of Global Hematology Diagnostics Market
- Segmentation of Global Hematology Diagnostics Market By Product (Instrument, Consumables)
- Segmentation of Global Hematology Diagnostics Market By Test Type (Blood Count, Platelet Function, Hemoglobin, Hematocrit)
- Segmentation of Global Hematology Diagnostics Market By End User (Hospitals, Diagnostic labs, Others)
- Statistical Snap of Global Hematology Diagnostics Market
- Expansion Analysis of Global Hematology Diagnostics Market
- Problems and Obstacles in Global Hematology Diagnostics Market
- Competitive Landscape in the Global Hematology Diagnostics Market
- Impact of COVID-19 and Demonetization on Global Hematology Diagnostics Market
- Details on Current Investment in Global Hematology Diagnostics Market
- Competitive Analysis of Global Hematology Diagnostics Market
- Prominent Players in the Global Hematology Diagnostics Market
- SWOT Analysis of Global Hematology Diagnostics Market
- Global Hematology Diagnostics Market Future Outlook and Projections (FY’2024-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1. Research data source2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPER’s internal database2.1.4. Premium insight from KOL’s2.2. Market size estimation2.2.1. Top-down and Bottom-up approach2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges4.2. COVID-19 Impacts of the Global Hematology Diagnostics Market.
5. Market variable and outlook
5.1. SWOT Analysis5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats5.2. PESTEL Analysis5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape5.3. PORTER’s Five Forces5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Hematology Diagnostics Market Manufacturing Base Distribution, Sales Area, Product Type6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Hematology Diagnostics Market
7. Global Hematology Diagnostics Market, By Product (USD Million) 2020-2033
7.1. Global Hematology Diagnostics Market Size, Share and Forecast, By Product, 2020-20267.2. Global Hematology Diagnostics Market Size, Share and Forecast, By Product, 2027-20337.3. Instrument7.3.1. Analyzers7.3.2. Flow cytometers7.3.3. Others7.4. Consumables7.4.1. Analyzers7.4.2. Flow cytometers7.4.3. Others
8. Global Hematology Diagnostics Market, By Test Type (USD Million) 2020-2033
8.1. Global Hematology Diagnostics Market Size, Share and Forecast, By Test Type, 2020-20268.2. Global Hematology Diagnostics Market Size, Share and Forecast, By Test Type, 2027-20338.3. Blood count8.4. Platelet function8.5. Hemoglobin8.6. Hematocrit
9. Global Hematology Diagnostics Market, By End User (USD Million) 2020-2033
9.1. Global Hematology Diagnostics Market Size, Share and Forecast, By End User, 2020-20269.2. Global Hematology Diagnostics Market Size, Share and Forecast, By End User, 2027-20339.3. Hospitals9.4. Diagnostic labs9.5. Others
10. Global Hematology Diagnostics Market Forecast, 2020-2033 (USD Million)
10.1. Global Hematology Diagnostics Market Size and Market Share
11. Global Hematology Diagnostics Market, By Region, 2020-2033 (USD Million)
11.1. Global Hematology Diagnostics Market Size and Market Share By Region (2020-2026)11.2. Global Hematology Diagnostics Market Size and Market Share By Region (2027-2033)11.3. Asia-Pacific11.3.1. Australia11.3.2. China11.3.3. India11.3.4. Japan11.3.5. South Korea11.3.6. Rest of Asia-Pacific11.4. Europe11.4.1. France11.4.2. Germany11.4.3. Italy11.4.4. Spain11.4.5. United Kingdom11.4.6. Rest of Europe11.5. Middle East and Africa11.5.1. Kingdom of Saudi Arabia11.5.2. United Arab Emirates11.5.3. Qatar11.5.4. South Africa11.5.5. Egypt11.5.6. Morocco11.5.7. Nigeria11.5.8. Rest of Middle-East and Africa11.6. North America11.6.1. Canada11.6.2. Mexico11.6.3. United States11.7. Latin America11.7.1. Argentina11.7.2. Brazil11.7.3. Rest of Latin America
12. Company Profile
12.1. Abbott Laboratories12.1.1. Company details12.1.2. Financial outlook12.1.3. Product summary12.1.4. Recent developments12.2. Cardinal Health Inc.12.2.1. Company details12.2.2. Financial outlook12.2.3. Product summary12.2.4. Recent developments12.3. Danaher Corporation12.3.1. Company details12.3.2. Financial outlook12.3.3. Product summary12.3.4. Recent developments12.4. EKF Diagnostics Holdings plc12.4.1. Company details12.4.2. Financial outlook12.4.3. Product summary12.4.4. Recent developments12.5. Erba Mannheim12.5.1. Company details12.5.2. Financial outlook12.5.3. Product summary12.5.4. Recent developments12.6. F. Hoffmann-La Roche Ltd.12.6.1. Company details12.6.2. Financial outlook12.6.3. Product summary12.6.4. Recent developments12.7. Nihon Kohden Corporation12.7.1. Company details12.7.2. Financial outlook12.7.3. Product summary12.7.4. Recent developments12.8. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.12.8.1. Company details12.8.2. Financial outlook12.8.3. Product summary12.8.4. Recent developments12.9. Siemens AG12.9.1. Company details12.9.2. Financial outlook12.9.3. Product summary12.9.4. Recent developments12.10. Sysmex Corporation12.10.1. Company details12.10.2. Financial outlook12.10.3. Product summary12.10.4. Recent developments12.11. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
The high cost of advanced diabetes drugs and the financial burden of treating diabetes remain major obstacles to market growth, despite the fact that numerous drugs have been approved for the condition and that governments and industry players are launching numerous initiatives.
Hematology Diagnostics Market is projected to reach USD 17.68 billion by 2033, growing at a CAGR of 4.64% during the forecast period.
Hematology Diagnostics Market grew in Market size from 2024. The Market is expected to reach USD 17.68 billion by 2033, at a CAGR of 4.64% during the forecast period.
Hematology Diagnostics Market CAGR of 4.64% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Hematology Diagnostics Market size is USD 17.68 billion from 2024 to 2033.
Hematology Diagnostics Market is covered By Product, By Test Type and By End User
The North America is anticipated to have the highest Market share in the Hematology Diagnostics Market.
The Key players in the Market include Companies Covered Abbott Laboratories, Cardinal Health Inc., Danaher Corporation, EKF Diagnostics Holdings plc, Erba Mannheim, F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens AG, Sysmex Corporation.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
